| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 5,127,000 | 4,889,000 | 4,839,000 | 5,469,000 | | Cost of Revenue | 4,081,000 | 3,933,000 | 3,853,000 | 5,374,000 | | | Gross Profit | 1,046,000 | 956,000 | 986,000 | 95,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 904,000 | 877,000 | 895,000 | (1,207,000) | | Non Recurring | 64,000 | 23,000 | 13,000 | 1,213,000 | | Others | 272,000 | 282,000 | 272,000 | 285,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (194,000) | (226,000) | (194,000) | (196,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (24,000) | (17,000) | 5,000 | 33,000 | | Earnings Before Interest And Taxes | (218,000) | (243,000) | (189,000) | (163,000) | | Interest Expense | 171,000 | 147,000 | 186,000 | 177,000 | | Income Before Tax | (389,000) | (390,000) | (375,000) | (340,000) | | Income Tax Expense | (30,000) |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (359,000) | (390,000) | (375,000) | (340,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (359,000) | (390,000) | (375,000) | (340,000) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($359,000) | ($390,000) | ($375,000) | ($340,000) |
|
0.42% Nasdaq 
Income Statement
